Wong, F.H.; Palanirajan, V.K.; Ng, E.S.C.; Tan, C.K.; Tan, E.S.S.; Amini, F.
Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines. Pharmaceuticals 2022, 15, 1075.
https://doi.org/10.3390/ph15091075
AMA Style
Wong FH, Palanirajan VK, Ng ESC, Tan CK, Tan ESS, Amini F.
Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines. Pharmaceuticals. 2022; 15(9):1075.
https://doi.org/10.3390/ph15091075
Chicago/Turabian Style
Wong, Fu Hou, Vijayaraj Kumar Palanirajan, Edmond Siah Chye Ng, Chung Keat Tan, Eugenie Sin Sing Tan, and Farahnaz Amini.
2022. "Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines" Pharmaceuticals 15, no. 9: 1075.
https://doi.org/10.3390/ph15091075
APA Style
Wong, F. H., Palanirajan, V. K., Ng, E. S. C., Tan, C. K., Tan, E. S. S., & Amini, F.
(2022). Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines. Pharmaceuticals, 15(9), 1075.
https://doi.org/10.3390/ph15091075